Chief Executive, Gilead Sciences
Appears in 1 story
Last updated Nov 3, 2026
Steering lenacapavir pricing and supply deals
On Nov. 2, the U.S. Food and Drug Administration gave tentative approval to a generic version of lenacapavir made by India's Dr. Reddy's Laboratories. The twice-yearly shot is expected to sell for about $40 per person per year in 120 low- and middle-income countries. It cannot be sold in the U.S.
Updated 5 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
